Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biocruces Bizkaia (35)

2024

  1. Prognostic factors for falls in Parkinson’s disease: a systematic review

    Acta Neurologica Belgica, Vol. 124, Núm. 2, pp. 395-406

2023

  1. Brain Degeneration in Synucleinopathies Based on Analysis of Cognition and Other Nonmotor Features: A Multimodal Imaging Study

    Biomedicines, Vol. 11, Núm. 2

  2. Correction to: Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease (Journal of Neurology, (2023), 270, 1, (519-529), 10.1007/s00415-022-11427-x)

    Journal of Neurology

  3. Diagnostic classification of Parkinson’s disease based on non-motor manifestations and machine learning strategies

    Neural Computing and Applications, Vol. 35, Núm. 8, pp. 5603-5617

  4. Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome

    Journal of Translational Medicine, Vol. 21, Núm. 1

  5. Influence of ocular biometric factors on the defocus curve in an enlarged depth-of-focus intraocular lens

    International Ophthalmology, Vol. 43, Núm. 3, pp. 945-955

  6. Multiple system atrophy: Clinical, evolutive and histopathological characteristics of a series of cases

    Neurologia, Vol. 38, Núm. 9, pp. 609-616

  7. Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease

    Journal of Neurology, Vol. 270, Núm. 8, pp. 3821-3829

2022

  1. Brain fog of post-COVID-19 condition and Chronic Fatigue Syndrome, same medical disorder?

    Journal of Translational Medicine, Vol. 20, Núm. 1

  2. Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers

    Parkinsonism and Related Disorders, Vol. 96, pp. 29-35

  3. Heart-brain synchronization breakdown in Parkinson’s disease

    npj Parkinson's Disease, Vol. 8, Núm. 1

  4. Impact of Visual Impairment on Vision-Related Quality of Life in Parkinson's Disease

    Journal of Parkinson's Disease, Vol. 12, Núm. 5, pp. 1633-1643

  5. Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease

    Nature Reviews Neurology, Vol. 18, Núm. 4, pp. 203-220

  6. Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease

    Journal of Neurology

  7. Plasma and serum alpha-synuclein as a biomarker in Parkinson's disease: A meta-analysis

    Parkinsonism and Related Disorders, Vol. 99, pp. 107-115

  8. Potential Tear Biomarkers for the Diagnosis of Parkinson’s Disease—A Pilot Study

    Proteomes, Vol. 10, Núm. 1

  9. Spatial characterization of the effect of age and sex on macular layer thicknesses and foveal pit morphology

    PLoS ONE, Vol. 17, Núm. 12 December

2021

  1. Clinical long-term nocturnal sleeping disturbances and excessive daytime sleepiness in Parkinson's disease

    PLoS ONE, Vol. 16, Núm. 12 December

  2. Differential exposure to N-ethyl N-nitrosourea during pregnancy is relevant to the induction of glioma and PNSTs in the brain

    Neurotoxicology and Teratology, Vol. 86

  3. Foveal Remodeling of Retinal Microvasculature in Parkinson’s Disease

    Frontiers in Neuroscience, Vol. 15